The Rosen Law Firm announces that it is investigating potential securities fraud claims against Galena Biopharma, Inc. (NASDAQ:GALE) resulting from allegations that GALE may have paid outsiders to pump its stock using false and misleading articles while insiders dumped their shares.
In July 2013, GALE entered into a contract with investor relations firm The DreamTeam Group (“DT”) to tout its stock for 240 days. DT itself then published a variety of articles, many if not all of which misleadingly omitted to disclose that DT was paid by GALE to promote it. Several of the articles were also falsely attributed to various third parties.
But in January 2014, before Mr. Feuerstein revealed that positive articles about GALE had been written in a paid promotional campaign, GALE CEO Mark J. Ahn sold net $2.79 million of GALE stock. Steven Kriegsman, a GALE Director who is also CEO of CytRX, another DT client, sold net $2.49 million of shares in January. Other insiders collectively sold net $4.7 million of shares.The Rosen Law Firm is investigating a securities class action lawsuit on behalf of GALE investors. If you purchased GALE stock before February 12, 2014, please visit the website at http://rosenlegal.com for more information. You may also contact Jonathan Horne, Esq., or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at firstname.lastname@example.org or email@example.com. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV